Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder that can cause multiple kidney cysts and problems beyond the kidneys. A cyst found on a scan is not, by itself, a diagnosis of ADPKD. The pattern, age, family history and relevant testing all help establish the explanation. [1][2]

In this guide: What can ADPKD affect? · How are imaging and genetic testing used? · Which genes are involved? · What should the care plan cover? · How does ADPKD affect family decisions? · What outcomes matter in ADPKD studies? · Related guides and practical tools

What can ADPKD affect?

Kidney cysts can enlarge the kidneys and affect kidney function. Possible complications include high blood pressure, pain, blood in the urine, stones and infection. Liver cysts and some vascular complications can also occur. The severity and timing vary; the condition should not be reduced to a single predicted age of kidney failure. [1]

For a consultation, bring the imaging report rather than only a statement that “cysts were seen.” Record blood pressure readings, kidney-function results and relevant family diagnoses. Note dates so that the clinician can distinguish one measurement from a trend.

How are imaging and genetic testing used?

Diagnosis uses age-appropriate imaging criteria and family or molecular evidence. The significance of an apparently reassuring scan depends on age and the clinical context. Genetic testing can help in selected situations, including uncertain findings or clarification of a family cause. [2]

  1. Define the question. Is this assessment of symptoms, an incidental scan finding, a relative at risk or another clinical decision?
  2. Read the imaging description. Record the modality, distribution of cysts, kidney size and the radiologist’s conclusion.
  3. Assemble clinical evidence. Bring kidney-function and blood pressure results with dates.
  4. Clarify the family history. Distinguish confirmed ADPKD from unspecified kidney disease.
  5. Discuss molecular testing. Ask whether it would change the conclusion or help relatives.
  6. Agree a follow-up plan. Record what is established, what is uncertain and who reviews the next results.
ADPKD assessment brings imaging, family history and genetic testing into clinical interpretation.
ADPKD assessment brings imaging, family history and genetic testing into clinical interpretation. Original educational schematic; see article for sources and limits.

Open full-size illustration (new tab)

Which genes are involved?

PKD1 and PKD2 are the major genes, but less common genes can produce related presentations. A negative result on a restricted test may therefore leave relevant questions unresolved. The companion PKD1 and PKD2 guide explains molecular interpretation and technical challenges. [3]

ADPKD and autosomal recessive polycystic kidney disease are distinct diagnoses with different inheritance patterns. Do not assume that every use of “polycystic kidney disease” in a family record refers to the same condition. Ask for the original diagnosis and testing information. [1]

What should the care plan cover?

Management addresses blood pressure, kidney function and complications such as pain or infection. A nephrology team can assess progression risk and discuss treatment choices. Keep a record of symptoms and results rather than changing medicines or fluid intake from a general online recommendation. [4]

Some adults with ADPKD may be considered for treatment to slow progression, including tolvaptan when appropriate. Selection and monitoring require specialist assessment; the KDIGO guidance includes criteria, contraindications and monitoring considerations. A cyst count or gene name alone does not establish eligibility. [5]

  • What supports the diagnosis, and is further clarification needed?
  • Which results will be followed over time, and how often?
  • What blood pressure plan is appropriate for me?
  • Does my personal or family history warrant assessment of complications outside the kidneys?
  • Which treatment options fit my progression risk and circumstances?
  • What symptoms should prompt urgent or earlier contact?

How does ADPKD affect family decisions?

In the usual autosomal dominant setting, each child of a person with a causative variant has a 50% probability of inheriting it. That probability does not predict the severity or timing of kidney problems. Family testing and reproductive discussions should use the confirmed diagnosis and available molecular evidence. [3]

A useful family worksheet separates “diagnosed,” “tested for the known variant,” “imaging performed” and “not assessed.” These are not interchangeable states. Discuss the implications of testing before ordering it, especially when the result would affect a consequential decision such as potential kidney donation.

What outcomes matter in ADPKD studies?

Distinguish kidney size, estimated filtration function, symptoms and events such as kidney replacement therapy. Ask which outcome the study measured, how quickly it changed, and how that relates to the claim in the headline. A biological or imaging change does not automatically demonstrate the same degree of patient-important benefit.

Original reading exercise: compare two studies by making rows for baseline age, kidney function, imaging criteria, treatment exposure, follow-up and outcome definition. If one group starts with more advanced disease, record that difference before comparing percentages. Our risk-reading guide helps keep denominators and time periods explicit.

Related guides and practical tools

Read the PKD1 and PKD2 guide, Alport syndrome guide and cascade testing guide. Use the variant research assistant, care finder and literature tools to organize evidence and locate professional directories.

Educational information, not an individual diagnosis or treatment plan. The current specialist-review status appears above. Illustrations are original educational examples, not patient records.